DuPont de Nemours (NYSE:DD) Stock Price Expected to Rise, UBS Group Analyst Says

DuPont de Nemours (NYSE:DDGet Free Report) had its target price lifted by analysts at UBS Group from $56.00 to $59.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the basic materials company’s stock. UBS Group’s price objective indicates a potential upside of 18.01% from the company’s current price.

Several other equities analysts have also recently commented on the stock. Wells Fargo & Company upped their target price on shares of DuPont de Nemours from $50.00 to $55.00 and gave the company an “overweight” rating in a research note on Wednesday, February 11th. Royal Bank Of Canada cut their target price on shares of DuPont de Nemours from $60.00 to $56.00 and set an “outperform” rating for the company in a research note on Friday, April 24th. Morgan Stanley upped their target price on shares of DuPont de Nemours from $44.00 to $52.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 28th. Wall Street Zen upgraded shares of DuPont de Nemours to a “hold” rating in a research note on Saturday, January 10th. Finally, Citigroup dropped their price objective on shares of DuPont de Nemours from $59.00 to $56.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Twelve equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, DuPont de Nemours has a consensus rating of “Moderate Buy” and a consensus price target of $54.79.

Check Out Our Latest Stock Analysis on DD

DuPont de Nemours Stock Performance

Shares of DuPont de Nemours stock traded up $0.76 on Wednesday, reaching $50.00. The stock had a trading volume of 6,021,316 shares, compared to its average volume of 4,319,235. The business’s 50-day moving average price is $46.47 and its two-hundred day moving average price is $43.14. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.91 and a current ratio of 2.42. DuPont de Nemours has a fifty-two week low of $26.82 and a fifty-two week high of $52.66. The stock has a market cap of $20.49 billion, a P/E ratio of -26.88, a price-to-earnings-growth ratio of 1.57 and a beta of 1.02.

DuPont de Nemours (NYSE:DDGet Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The basic materials company reported $0.55 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.07. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the previous year, the company earned $1.03 earnings per share. DuPont de Nemours’s revenue for the quarter was up 4.3% on a year-over-year basis. DuPont de Nemours has set its Q2 2026 guidance at 0.590-0.590 EPS and its FY 2026 guidance at 2.350-2.400 EPS. On average, sell-side analysts forecast that DuPont de Nemours will post 2.27 EPS for the current year.

Institutional Investors Weigh In On DuPont de Nemours

Large investors have recently made changes to their positions in the company. Palisade Asset Management LLC bought a new stake in shares of DuPont de Nemours in the 3rd quarter worth about $26,000. Financial Life Planners bought a new stake in shares of DuPont de Nemours in the 3rd quarter worth about $27,000. Imprint Wealth LLC bought a new stake in shares of DuPont de Nemours in the 3rd quarter worth about $27,000. Measured Wealth Private Client Group LLC bought a new stake in shares of DuPont de Nemours in the 3rd quarter worth about $30,000. Finally, Crews Bank & Trust grew its holdings in shares of DuPont de Nemours by 55.8% in the 3rd quarter. Crews Bank & Trust now owns 508 shares of the basic materials company’s stock worth $40,000 after purchasing an additional 182 shares during the last quarter. Institutional investors own 73.96% of the company’s stock.

Key DuPont de Nemours News

Here are the key news stories impacting DuPont de Nemours this week:

  • Positive Sentiment: Q1 beat and upgraded outlook — DuPont reported adjusted EPS $0.55 vs. consensus $0.48, revenue rose ~4% YoY, and the company raised full?year 2026 EPS guidance to $2.35–$2.40 and Q2 EPS to $0.59. The company cited productivity gains and stronger healthcare/aerospace demand as drivers. DuPont Reports First Quarter 2026 Results
  • Positive Sentiment: $275M share buyback announced — Management said it will launch an accelerated share repurchase (ASR) of $275 million, which supports EPS and signals capital return priority. DuPont Lifts Outlook, Plans $275 Million Buyback
  • Positive Sentiment: Analyst optimism — BMO Capital Markets raised its price target to $60 and kept an Outperform rating, adding upside to sentiment and potentially supporting further buying. MarketScreener
  • Positive Sentiment: Market reaction — Media and market pieces highlight a sharp rally after the print and outlook raise, noting the stock reached multi?month highs as investors priced in momentum. DuPont rallies after strong results—more upside ahead?
  • Neutral Sentiment: Earnings materials available — Full earnings call transcript and investor presentation provide more detail on segment performance, cost actions and guidance assumptions for those modeling forward cash flow. Earnings Call Transcript Earnings Presentation
  • Negative Sentiment: Underlying volatility and margin context — GAAP metrics show swings (GAAP EPS and net margin remain less steady), and last year’s EPS was higher, underscoring earnings volatility that could pressure valuations if end?market demand softens. Review the detailed metric comparison before assuming the beat signals sustained margin expansion. DD Q1 Earnings Beat on Productivity Gains, Sales Rise Y/Y

DuPont de Nemours Company Profile

(Get Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Recommended Stories

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.